Best Telehealth Clinics in Connecticut (2026)

Connecticut's telehealth statute is codified at CGS § 19a-906, most recently updated by Public Act 24-110. The law defines telehealth broadly and includes audio-only telephone as a valid modality — more permissive than states that require video for all telehealth encounters. Fax, texting, and email are excluded from the telehealth definition.

Connecticut does not impose a blanket in-person visit requirement before prescribing controlled substances via telehealth. The state relies on the federal DEA framework, which permits telehealth prescribing of Schedule II through V substances through the December 2026 flexibility extension. Standard-of-care requirements are the same for telehealth and in-person encounters.

Connecticut has an unusual IMLC status. The state can issue licenses through the Interstate Medical Licensure Compact, but it cannot serve as a State of Principal License (SPL) for entry into the compact. This means physicians whose primary license is in Connecticut cannot use the IMLC to get licensed in other states. However, physicians from other IMLC states can get expedited Connecticut licensure. This one-directional compact status does not limit telehealth provider availability for Connecticut patients.

Payment parity is required — insurers cannot reduce reimbursement for telehealth services compared to in-person care. Connecticut had a temporary cross-state behavioral health provider registration pathway that expired June 30, 2025.

Connecticut grants full practice authority to nurse practitioners after 3 years and 2,000 or more hours of collaborative practice with a physician. Before reaching that threshold, collaborative agreements are required. Connecticut is not a member of the Nurse Licensure Compact (NLC), which is a separate compact from the IMLC and affects nursing licensure portability.

Connecticut does not tax prescription medications or over-the-counter medications — more generous than most states, which only exempt prescriptions. The state has a progressive income tax with a top marginal rate of 6.99%.

Connecticut has 3.6 million residents. Provider availability is good, supported by the ability to receive IMLC licenses (even with the SPL limitation) and no in-person requirement for controlled substances. Most national telehealth platforms serve the state.

All major TRT providers serve Connecticut. Maximus ($100/mo, all 50 states), Hone Health ($25/mo, all 50 states), TRT Nation ($99/mo, 45 states including CT), BraverX ($129/mo), PeterMD ($99/mo), DudeMeds ($77/mo), and Titan Medical ($99/mo) are available. Enhance MD also serves Connecticut.

GLP-1 availability is unrestricted. Embody, SkinnyRx, DirectMeds, Zealthy, Remedy Meds, GobyMeds, Sesame Care, MEDVi, Shed, Sunlight, and Mochi Health all serve Connecticut. Connecticut Medicaid (HUSKY Health) does not cover GLP-1s for obesity.

All HRT, hair loss, and ED providers with national coverage serve Connecticut. Midi Health accepts insurance. No known state-specific provider exclusions for CT.

TRT pricing from available providers: DudeMeds $77/mo ($1,124/year), TRT Nation $99/mo ($1,446/year), PeterMD $99/mo ($1,188/year), Maximus $100/mo ($1,300/year), BraverX $129/mo ($1,548/year), Defy Medical $200/mo ($2,800/year).

GLP-1 ranges from $99/mo to $399/mo. Median is $179/mo. HUSKY Health (Connecticut Medicaid) does not cover GLP-1s for obesity. Patients must pay out of pocket or use commercial insurance.

Connecticut does not tax prescription medications or OTC medications. The state sales tax is 6.35% but all medications are exempt. Connecticut has a progressive income tax with rates from 2% to 6.99%.

HRT: Midi Health (insurance), PlushCare ($20/mo), Evernow ($35/mo), Alloy ($49/mo). ED: Hims $17/mo to MEDVi $119/mo.

Connecticut has a high cost of living, particularly in Fairfield County and the greater Hartford area. Telehealth pricing is national and does not vary by metro area.

TRT (testosterone replacement therapy)

Connecticut does not require an in-person visit for TRT prescribing via telehealth. The federal DEA waiver through December 2026 applies. Audio-only telehealth is permitted under CGS § 19a-906, though most TRT providers use video. Both compounded and FDA-approved testosterone are available. NPs with 3+ years experience can prescribe independently.

GLP-1 weight loss

No state-specific GLP-1 restrictions in Connecticut. Federal FDA compounding rules apply. HUSKY Health does not cover GLP-1s for obesity. Commercial insurance coverage varies by plan.

HRT (hormone replacement therapy)

HRT follows standard federal prescribing rules in Connecticut. No additional state restrictions apply.

Hair loss

Hair loss treatment follows standard federal prescribing rules in Connecticut. No additional state restrictions apply.

ED (erectile dysfunction)

ED treatment follows standard federal prescribing rules in Connecticut. No additional state restrictions apply.

Peptides

Peptide therapy follows standard federal rules in Connecticut. Non-controlled peptides have fewer restrictions. The IMLC receiving status supports provider availability.